Endocyte (ECYT) Tops Q3 EPS by 6c

Endocyte (NASDAQ: ECYT) reported Q3 EPS of ($0.21), $0.06 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Endocyte (ECYT) click here.

You May Also Be Interested In

• Delta Air Lines stock climbs on earnings beat and strong guidance
• Cohu (COHU) PT Raised to $70 at Stifel on Expectation of 'More Buoyant Multiple'
• Stifel says AI infrastructure remains supply-gated into earnings